We thus knocked out METTL3 using the CRISPR/Cas9 system in lung cancer cells, and the knockout efficiency was confirmed by both western bolt (Fig. 2B) and dot blot (Additional file 1: Fig. S2G). The gene discussed is METTL3; the disease is lung carcinoma.